Received: 4 June 2019
Accepted: 1 July 2020
First Online: 14 July 2020
Ethics approval and consent to participate
: Animal care and experimental procedures were in accordance with the accredited animal ethics committee of the Hebrew University Medical School.
: Not applicable.
: JBT is a director in SyndromeX. SyndromeX develops drugs for the Metabolic Syndrome.